On September 28, 2023, Yunnan Jianzhijia Chongqing Qinkang Pharmaceutical Co., Ltd. closed the transaction. The company announced that it has completed the change registration procedures, and obtained a new "Business License". The registered capital of the company is CNY 80 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
51.5 CNY | -1.25% | +1.72% | -13.30% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.30% | 931M | |
-30.37% | 15.82B | |
-22.51% | 12.65B | |
-22.88% | 6.6B | |
+11.76% | 6.3B | |
-6.01% | 6.11B | |
+64.02% | 4.75B | |
-1.17% | 4.69B | |
-5.58% | 4.02B | |
-7.87% | 3.59B |
- Stock Market
- Equities
- 605266 Stock
- News Jianzhijia Pharmaceutical Chain Group Co., Ltd.
- Yunnan Jianzhijia Chongqing Qinkang Pharmaceutical Co., Ltd. announced that it has received CNY 50 million in funding from Jianzhijia Pharmaceutical Chain Group Co., Ltd.